Clinical Roundup Positive phase II data reported on Regeneron’s odronextamab in R/R DLBCL December 16, 2022Vol.48 No.45
Clinical Roundup Kisqali prolonged PFS for metastatic breast cancer vs. chemo December 09, 2022Vol.48 No.44
Clinical Roundup AstraZeneca’s capivasertib + Faslodex demonstrates PFS improvement in breast cancer in phase III trial December 09, 2022Vol.48 No.44
Clinical Roundup Study finds expanded predictive value of Breast Cancer Index for ovarian function suppression in SOFT trial December 09, 2022Vol.48 No.44
Clinical Roundup Race shown to predict survival disparities in head and neck cancer clinical trials December 09, 2022Vol.48 No.44
Clinical Roundup Menthol cigarette alternatives pose significant addiction and health risks December 09, 2022Vol.48 No.44
Clinical Roundup UCSF researchers uncover pathway for molecular cancer drug therapies December 09, 2022Vol.48 No.44
Clinical Roundup CRUK, University of Manchester, Roche trial opens for people with rare and pediatric cancers December 09, 2022Vol.48 No.44
Clinical Roundup Keytruda meets primary endpoint of OS in HER2-negative gastric cancer December 02, 2022Vol.48 No.43
Clinical Roundup Adjuvant Keytruda provides higher QoL than standard of care immunotherapy in melanoma December 02, 2022Vol.48 No.43
